nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—ABCB1—kidney cancer	0.186	1	CbGaD
Trimipramine—ABCB1—Temsirolimus—kidney cancer	0.0442	0.0795	CbGbCtD
Trimipramine—HTR2C—Sorafenib—kidney cancer	0.0423	0.0762	CbGbCtD
Trimipramine—CYP2D6—Temsirolimus—kidney cancer	0.0416	0.075	CbGbCtD
Trimipramine—CYP3A4—Everolimus—kidney cancer	0.0392	0.0706	CbGbCtD
Trimipramine—CYP3A4—Temsirolimus—kidney cancer	0.0265	0.0477	CbGbCtD
Trimipramine—CYP2C9—Capecitabine—kidney cancer	0.025	0.0449	CbGbCtD
Trimipramine—ABCB1—Pazopanib—kidney cancer	0.0232	0.0418	CbGbCtD
Trimipramine—CYP2D6—Pazopanib—kidney cancer	0.0219	0.0394	CbGbCtD
Trimipramine—ABCB1—Dactinomycin—kidney cancer	0.0212	0.0382	CbGbCtD
Trimipramine—ABCB1—Gemcitabine—kidney cancer	0.0168	0.0302	CbGbCtD
Trimipramine—CYP2C19—Sorafenib—kidney cancer	0.0167	0.03	CbGbCtD
Trimipramine—ABCB1—Erlotinib—kidney cancer	0.0166	0.0298	CbGbCtD
Trimipramine—CYP2C9—Paclitaxel—kidney cancer	0.0156	0.0281	CbGbCtD
Trimipramine—CYP2D6—Erlotinib—kidney cancer	0.0156	0.0281	CbGbCtD
Trimipramine—ABCB1—Paclitaxel—kidney cancer	0.0152	0.0273	CbGbCtD
Trimipramine—CYP3A4—Pazopanib—kidney cancer	0.0139	0.025	CbGbCtD
Trimipramine—CYP2C9—Sorafenib—kidney cancer	0.0139	0.025	CbGbCtD
Trimipramine—ABCB1—Sorafenib—kidney cancer	0.0135	0.0242	CbGbCtD
Trimipramine—ABCB1—Vinblastine—kidney cancer	0.0133	0.0239	CbGbCtD
Trimipramine—ABCB1—Vincristine—kidney cancer	0.0131	0.0235	CbGbCtD
Trimipramine—CYP2D6—Sorafenib—kidney cancer	0.0127	0.0228	CbGbCtD
Trimipramine—CYP2D6—Vinblastine—kidney cancer	0.0125	0.0226	CbGbCtD
Trimipramine—ABCB1—Sunitinib—kidney cancer	0.0109	0.0196	CbGbCtD
Trimipramine—CYP3A4—Erlotinib—kidney cancer	0.00993	0.0179	CbGbCtD
Trimipramine—CYP3A4—Paclitaxel—kidney cancer	0.00909	0.0164	CbGbCtD
Trimipramine—ABCB1—Doxorubicin—kidney cancer	0.00817	0.0147	CbGbCtD
Trimipramine—CYP3A4—Sorafenib—kidney cancer	0.00807	0.0145	CbGbCtD
Trimipramine—CYP3A4—Vinblastine—kidney cancer	0.00797	0.0143	CbGbCtD
Trimipramine—CYP3A4—Vincristine—kidney cancer	0.00784	0.0141	CbGbCtD
Trimipramine—CYP2D6—Doxorubicin—kidney cancer	0.0077	0.0139	CbGbCtD
Trimipramine—CYP3A4—Sunitinib—kidney cancer	0.00654	0.0118	CbGbCtD
Trimipramine—CYP3A4—Doxorubicin—kidney cancer	0.0049	0.00881	CbGbCtD
Trimipramine—CYP2C19—urine—kidney cancer	0.00129	0.134	CbGeAlD
Trimipramine—Dimetacrine—ACHE—kidney cancer	0.00119	0.352	CrCbGaD
Trimipramine—CYP2C9—urine—kidney cancer	0.000998	0.104	CbGeAlD
Trimipramine—HTR2A—urine—kidney cancer	0.000822	0.0853	CbGeAlD
Trimipramine—CYP3A4—urine—kidney cancer	0.000761	0.0789	CbGeAlD
Trimipramine—CYP2D6—urine—kidney cancer	0.000749	0.0777	CbGeAlD
Trimipramine—ADRA1B—renal system—kidney cancer	0.000554	0.0574	CbGeAlD
Trimipramine—ADRA1B—kidney—kidney cancer	0.000535	0.0555	CbGeAlD
Trimipramine—Ethopropazine—BCHE—kidney cancer	0.000417	0.123	CrCbGaD
Trimipramine—HTR1D—kidney—kidney cancer	0.000391	0.0406	CbGeAlD
Trimipramine—Clomipramine—GSTP1—kidney cancer	0.00035	0.103	CrCbGaD
Trimipramine—HTR1A—renal system—kidney cancer	0.000337	0.035	CbGeAlD
Trimipramine—ADRA1A—renal system—kidney cancer	0.000311	0.0323	CbGeAlD
Trimipramine—Fatigue—Sorafenib—kidney cancer	0.000307	0.00161	CcSEcCtD
Trimipramine—Hypertension—Vincristine—kidney cancer	0.000306	0.00161	CcSEcCtD
Trimipramine—Constipation—Sorafenib—kidney cancer	0.000304	0.00159	CcSEcCtD
Trimipramine—Malaise—Gemcitabine—kidney cancer	0.000304	0.00159	CcSEcCtD
Trimipramine—Weight increased—Capecitabine—kidney cancer	0.000302	0.00158	CcSEcCtD
Trimipramine—Tinnitus—Paclitaxel—kidney cancer	0.000302	0.00158	CcSEcCtD
Trimipramine—Dyspepsia—Sunitinib—kidney cancer	0.000301	0.00158	CcSEcCtD
Trimipramine—Flushing—Paclitaxel—kidney cancer	0.000301	0.00157	CcSEcCtD
Trimipramine—SLC6A2—gonad—kidney cancer	0.0003	0.0311	CbGeAlD
Trimipramine—Decreased appetite—Sunitinib—kidney cancer	0.000298	0.00156	CcSEcCtD
Trimipramine—Asthenia—Vinblastine—kidney cancer	0.000295	0.00155	CcSEcCtD
Trimipramine—Fatigue—Sunitinib—kidney cancer	0.000295	0.00155	CcSEcCtD
Trimipramine—Asthenia—Everolimus—kidney cancer	0.000294	0.00154	CcSEcCtD
Trimipramine—Constipation—Sunitinib—kidney cancer	0.000293	0.00153	CcSEcCtD
Trimipramine—Acute coronary syndrome—Capecitabine—kidney cancer	0.000292	0.00153	CcSEcCtD
Trimipramine—Hypertension—Gemcitabine—kidney cancer	0.000291	0.00152	CcSEcCtD
Trimipramine—Neuropathy peripheral—Capecitabine—kidney cancer	0.00029	0.00152	CcSEcCtD
Trimipramine—Myocardial infarction—Capecitabine—kidney cancer	0.00029	0.00152	CcSEcCtD
Trimipramine—Pruritus—Everolimus—kidney cancer	0.00029	0.00152	CcSEcCtD
Trimipramine—Oedema—Vincristine—kidney cancer	0.00029	0.00152	CcSEcCtD
Trimipramine—Arrhythmia—Paclitaxel—kidney cancer	0.000289	0.00152	CcSEcCtD
Trimipramine—Stomatitis—Capecitabine—kidney cancer	0.000289	0.00151	CcSEcCtD
Trimipramine—Jaundice—Capecitabine—kidney cancer	0.000289	0.00151	CcSEcCtD
Trimipramine—Alopecia—Paclitaxel—kidney cancer	0.000286	0.0015	CcSEcCtD
Trimipramine—Asthenia—Erlotinib—kidney cancer	0.000284	0.00149	CcSEcCtD
Trimipramine—Thrombocytopenia—Vincristine—kidney cancer	0.000284	0.00149	CcSEcCtD
Trimipramine—Discomfort—Gemcitabine—kidney cancer	0.000283	0.00148	CcSEcCtD
Trimipramine—Urticaria—Sorafenib—kidney cancer	0.000283	0.00148	CcSEcCtD
Trimipramine—Decreased appetite—Dactinomycin—kidney cancer	0.000282	0.00148	CcSEcCtD
Trimipramine—Diarrhoea—Vinblastine—kidney cancer	0.000282	0.00148	CcSEcCtD
Trimipramine—Abdominal pain—Sorafenib—kidney cancer	0.000281	0.00147	CcSEcCtD
Trimipramine—Body temperature increased—Sorafenib—kidney cancer	0.000281	0.00147	CcSEcCtD
Trimipramine—Diarrhoea—Everolimus—kidney cancer	0.000281	0.00147	CcSEcCtD
Trimipramine—Pruritus—Erlotinib—kidney cancer	0.00028	0.00147	CcSEcCtD
Trimipramine—Fatigue—Dactinomycin—kidney cancer	0.00028	0.00146	CcSEcCtD
Trimipramine—Vascular purpura—Doxorubicin—kidney cancer	0.000277	0.00145	CcSEcCtD
Trimipramine—Agranulocytosis—Capecitabine—kidney cancer	0.000276	0.00145	CcSEcCtD
Trimipramine—Anorexia—Vincristine—kidney cancer	0.000276	0.00145	CcSEcCtD
Trimipramine—Dysgeusia—Paclitaxel—kidney cancer	0.000276	0.00145	CcSEcCtD
Trimipramine—Oedema—Gemcitabine—kidney cancer	0.000275	0.00144	CcSEcCtD
Trimipramine—Dizziness—Vinblastine—kidney cancer	0.000272	0.00143	CcSEcCtD
Trimipramine—Dizziness—Everolimus—kidney cancer	0.000271	0.00142	CcSEcCtD
Trimipramine—Abdominal pain—Sunitinib—kidney cancer	0.000271	0.00142	CcSEcCtD
Trimipramine—Body temperature increased—Sunitinib—kidney cancer	0.000271	0.00142	CcSEcCtD
Trimipramine—Diarrhoea—Erlotinib—kidney cancer	0.000271	0.00142	CcSEcCtD
Trimipramine—Hypotension—Vincristine—kidney cancer	0.000271	0.00142	CcSEcCtD
Trimipramine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000269	0.00141	CcSEcCtD
Trimipramine—Feeling abnormal—Dactinomycin—kidney cancer	0.000267	0.0014	CcSEcCtD
Trimipramine—Vision blurred—Paclitaxel—kidney cancer	0.000266	0.00139	CcSEcCtD
Trimipramine—Hypoaesthesia—Capecitabine—kidney cancer	0.000264	0.00139	CcSEcCtD
Trimipramine—Tremor—Paclitaxel—kidney cancer	0.000264	0.00138	CcSEcCtD
Trimipramine—Insomnia—Vincristine—kidney cancer	0.000262	0.00137	CcSEcCtD
Trimipramine—Anorexia—Gemcitabine—kidney cancer	0.000262	0.00137	CcSEcCtD
Trimipramine—Vomiting—Vinblastine—kidney cancer	0.000262	0.00137	CcSEcCtD
Trimipramine—Dizziness—Erlotinib—kidney cancer	0.000262	0.00137	CcSEcCtD
Trimipramine—Ill-defined disorder—Paclitaxel—kidney cancer	0.000262	0.00137	CcSEcCtD
Trimipramine—Vomiting—Everolimus—kidney cancer	0.000261	0.00137	CcSEcCtD
Trimipramine—Paraesthesia—Vincristine—kidney cancer	0.00026	0.00136	CcSEcCtD
Trimipramine—Agitation—Paclitaxel—kidney cancer	0.000259	0.00136	CcSEcCtD
Trimipramine—Rash—Everolimus—kidney cancer	0.000259	0.00135	CcSEcCtD
Trimipramine—Dermatitis—Everolimus—kidney cancer	0.000258	0.00135	CcSEcCtD
Trimipramine—Headache—Vinblastine—kidney cancer	0.000258	0.00135	CcSEcCtD
Trimipramine—Purpura—Doxorubicin—kidney cancer	0.000257	0.00135	CcSEcCtD
Trimipramine—Headache—Everolimus—kidney cancer	0.000257	0.00135	CcSEcCtD
Trimipramine—Hypotension—Gemcitabine—kidney cancer	0.000257	0.00135	CcSEcCtD
Trimipramine—Body temperature increased—Dactinomycin—kidney cancer	0.000256	0.00134	CcSEcCtD
Trimipramine—Abdominal pain—Dactinomycin—kidney cancer	0.000256	0.00134	CcSEcCtD
Trimipramine—Asthenia—Sorafenib—kidney cancer	0.000255	0.00134	CcSEcCtD
Trimipramine—Malaise—Paclitaxel—kidney cancer	0.000254	0.00133	CcSEcCtD
Trimipramine—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000253	0.00132	CcSEcCtD
Trimipramine—Decreased appetite—Vincristine—kidney cancer	0.000252	0.00132	CcSEcCtD
Trimipramine—Pruritus—Sorafenib—kidney cancer	0.000252	0.00132	CcSEcCtD
Trimipramine—Vomiting—Erlotinib—kidney cancer	0.000252	0.00132	CcSEcCtD
Trimipramine—Fatigue—Vincristine—kidney cancer	0.00025	0.00131	CcSEcCtD
Trimipramine—Rash—Erlotinib—kidney cancer	0.000249	0.00131	CcSEcCtD
Trimipramine—Dermatitis—Erlotinib—kidney cancer	0.000249	0.00131	CcSEcCtD
Trimipramine—Palpitations—Paclitaxel—kidney cancer	0.000249	0.00131	CcSEcCtD
Trimipramine—Insomnia—Gemcitabine—kidney cancer	0.000249	0.0013	CcSEcCtD
Trimipramine—Headache—Erlotinib—kidney cancer	0.000248	0.0013	CcSEcCtD
Trimipramine—Tinnitus—Capecitabine—kidney cancer	0.000248	0.0013	CcSEcCtD
Trimipramine—Constipation—Vincristine—kidney cancer	0.000248	0.0013	CcSEcCtD
Trimipramine—Paraesthesia—Gemcitabine—kidney cancer	0.000247	0.00129	CcSEcCtD
Trimipramine—Flushing—Capecitabine—kidney cancer	0.000247	0.00129	CcSEcCtD
Trimipramine—Asthenia—Sunitinib—kidney cancer	0.000246	0.00129	CcSEcCtD
Trimipramine—Nausea—Vinblastine—kidney cancer	0.000245	0.00128	CcSEcCtD
Trimipramine—Somnolence—Gemcitabine—kidney cancer	0.000244	0.00128	CcSEcCtD
Trimipramine—Convulsion—Paclitaxel—kidney cancer	0.000244	0.00128	CcSEcCtD
Trimipramine—Nausea—Everolimus—kidney cancer	0.000244	0.00128	CcSEcCtD
Trimipramine—Diarrhoea—Sorafenib—kidney cancer	0.000244	0.00128	CcSEcCtD
Trimipramine—Hypertension—Paclitaxel—kidney cancer	0.000243	0.00128	CcSEcCtD
Trimipramine—Pruritus—Sunitinib—kidney cancer	0.000242	0.00127	CcSEcCtD
Trimipramine—Anxiety—Paclitaxel—kidney cancer	0.000239	0.00125	CcSEcCtD
Trimipramine—Decreased appetite—Gemcitabine—kidney cancer	0.000239	0.00125	CcSEcCtD
Trimipramine—Arrhythmia—Capecitabine—kidney cancer	0.000237	0.00124	CcSEcCtD
Trimipramine—Discomfort—Paclitaxel—kidney cancer	0.000237	0.00124	CcSEcCtD
Trimipramine—Fatigue—Gemcitabine—kidney cancer	0.000237	0.00124	CcSEcCtD
Trimipramine—Dizziness—Sorafenib—kidney cancer	0.000235	0.00123	CcSEcCtD
Trimipramine—Constipation—Gemcitabine—kidney cancer	0.000235	0.00123	CcSEcCtD
Trimipramine—Nausea—Erlotinib—kidney cancer	0.000235	0.00123	CcSEcCtD
Trimipramine—Alopecia—Capecitabine—kidney cancer	0.000235	0.00123	CcSEcCtD
Trimipramine—Dry mouth—Paclitaxel—kidney cancer	0.000235	0.00123	CcSEcCtD
Trimipramine—Diarrhoea—Sunitinib—kidney cancer	0.000234	0.00123	CcSEcCtD
Trimipramine—Ataxia—Doxorubicin—kidney cancer	0.000233	0.00122	CcSEcCtD
Trimipramine—Asthenia—Dactinomycin—kidney cancer	0.000233	0.00122	CcSEcCtD
Trimipramine—Confusional state—Paclitaxel—kidney cancer	0.000232	0.00122	CcSEcCtD
Trimipramine—Oedema—Paclitaxel—kidney cancer	0.00023	0.00121	CcSEcCtD
Trimipramine—Abdominal pain—Vincristine—kidney cancer	0.000229	0.0012	CcSEcCtD
Trimipramine—Body temperature increased—Vincristine—kidney cancer	0.000229	0.0012	CcSEcCtD
Trimipramine—Dysgeusia—Capecitabine—kidney cancer	0.000227	0.00119	CcSEcCtD
Trimipramine—Dizziness—Sunitinib—kidney cancer	0.000226	0.00119	CcSEcCtD
Trimipramine—Feeling abnormal—Gemcitabine—kidney cancer	0.000226	0.00119	CcSEcCtD
Trimipramine—Vomiting—Sorafenib—kidney cancer	0.000226	0.00119	CcSEcCtD
Trimipramine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000225	0.00118	CcSEcCtD
Trimipramine—Tachycardia—Paclitaxel—kidney cancer	0.000225	0.00118	CcSEcCtD
Trimipramine—Rash—Sorafenib—kidney cancer	0.000224	0.00118	CcSEcCtD
Trimipramine—Dermatitis—Sorafenib—kidney cancer	0.000224	0.00117	CcSEcCtD
Trimipramine—Headache—Sorafenib—kidney cancer	0.000223	0.00117	CcSEcCtD
Trimipramine—ADRA2A—cortex of kidney—kidney cancer	0.000223	0.0231	CbGeAlD
Trimipramine—Diarrhoea—Dactinomycin—kidney cancer	0.000222	0.00116	CcSEcCtD
Trimipramine—Anorexia—Paclitaxel—kidney cancer	0.000219	0.00115	CcSEcCtD
Trimipramine—Vision blurred—Capecitabine—kidney cancer	0.000218	0.00114	CcSEcCtD
Trimipramine—Vomiting—Sunitinib—kidney cancer	0.000218	0.00114	CcSEcCtD
Trimipramine—Body temperature increased—Gemcitabine—kidney cancer	0.000217	0.00114	CcSEcCtD
Trimipramine—Tremor—Capecitabine—kidney cancer	0.000217	0.00114	CcSEcCtD
Trimipramine—Rash—Sunitinib—kidney cancer	0.000216	0.00113	CcSEcCtD
Trimipramine—Dermatitis—Sunitinib—kidney cancer	0.000216	0.00113	CcSEcCtD
Trimipramine—Hypotension—Paclitaxel—kidney cancer	0.000215	0.00113	CcSEcCtD
Trimipramine—Ill-defined disorder—Capecitabine—kidney cancer	0.000215	0.00112	CcSEcCtD
Trimipramine—Headache—Sunitinib—kidney cancer	0.000215	0.00112	CcSEcCtD
Trimipramine—ADRA2A—gonad—kidney cancer	0.000212	0.022	CbGeAlD
Trimipramine—Eosinophilia—Doxorubicin—kidney cancer	0.000212	0.00111	CcSEcCtD
Trimipramine—ADRA2A—cardiac atrium—kidney cancer	0.000212	0.022	CbGeAlD
Trimipramine—Nausea—Sorafenib—kidney cancer	0.000211	0.00111	CcSEcCtD
Trimipramine—Malaise—Capecitabine—kidney cancer	0.000209	0.00109	CcSEcCtD
Trimipramine—Insomnia—Paclitaxel—kidney cancer	0.000208	0.00109	CcSEcCtD
Trimipramine—Asthenia—Vincristine—kidney cancer	0.000208	0.00109	CcSEcCtD
Trimipramine—Paraesthesia—Paclitaxel—kidney cancer	0.000207	0.00108	CcSEcCtD
Trimipramine—Vomiting—Dactinomycin—kidney cancer	0.000206	0.00108	CcSEcCtD
Trimipramine—Somnolence—Paclitaxel—kidney cancer	0.000205	0.00107	CcSEcCtD
Trimipramine—Palpitations—Capecitabine—kidney cancer	0.000204	0.00107	CcSEcCtD
Trimipramine—Rash—Dactinomycin—kidney cancer	0.000204	0.00107	CcSEcCtD
Trimipramine—Nausea—Sunitinib—kidney cancer	0.000203	0.00107	CcSEcCtD
Trimipramine—Pancytopenia—Doxorubicin—kidney cancer	0.000203	0.00106	CcSEcCtD
Trimipramine—Dyspepsia—Paclitaxel—kidney cancer	0.000203	0.00106	CcSEcCtD
Trimipramine—HTR2A—renal system—kidney cancer	0.000201	0.0209	CbGeAlD
Trimipramine—Decreased appetite—Paclitaxel—kidney cancer	0.0002	0.00105	CcSEcCtD
Trimipramine—Hypertension—Capecitabine—kidney cancer	0.0002	0.00105	CcSEcCtD
Trimipramine—Fatigue—Paclitaxel—kidney cancer	0.000198	0.00104	CcSEcCtD
Trimipramine—Diarrhoea—Vincristine—kidney cancer	0.000198	0.00104	CcSEcCtD
Trimipramine—Pollakiuria—Doxorubicin—kidney cancer	0.000198	0.00104	CcSEcCtD
Trimipramine—Asthenia—Gemcitabine—kidney cancer	0.000197	0.00103	CcSEcCtD
Trimipramine—Constipation—Paclitaxel—kidney cancer	0.000197	0.00103	CcSEcCtD
Trimipramine—Anxiety—Capecitabine—kidney cancer	0.000196	0.00103	CcSEcCtD
Trimipramine—Weight increased—Doxorubicin—kidney cancer	0.000195	0.00102	CcSEcCtD
Trimipramine—Discomfort—Capecitabine—kidney cancer	0.000195	0.00102	CcSEcCtD
Trimipramine—Pruritus—Gemcitabine—kidney cancer	0.000194	0.00102	CcSEcCtD
Trimipramine—HTR2A—kidney—kidney cancer	0.000194	0.0202	CbGeAlD
Trimipramine—Dry mouth—Capecitabine—kidney cancer	0.000193	0.00101	CcSEcCtD
Trimipramine—Nausea—Dactinomycin—kidney cancer	0.000193	0.00101	CcSEcCtD
Trimipramine—Dizziness—Vincristine—kidney cancer	0.000192	0.001	CcSEcCtD
Trimipramine—Drowsiness—Doxorubicin—kidney cancer	0.000191	0.001	CcSEcCtD
Trimipramine—Confusional state—Capecitabine—kidney cancer	0.00019	0.000997	CcSEcCtD
Trimipramine—Feeling abnormal—Paclitaxel—kidney cancer	0.00019	0.000993	CcSEcCtD
Trimipramine—Nortriptyline—PTGS1—kidney cancer	0.000189	0.0558	CrCbGaD
Trimipramine—Oedema—Capecitabine—kidney cancer	0.000189	0.000989	CcSEcCtD
Trimipramine—Diarrhoea—Gemcitabine—kidney cancer	0.000188	0.000985	CcSEcCtD
Trimipramine—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000187	0.00098	CcSEcCtD
Trimipramine—CYP3A4—renal system—kidney cancer	0.000186	0.0193	CbGeAlD
Trimipramine—Jaundice—Doxorubicin—kidney cancer	0.000186	0.000975	CcSEcCtD
Trimipramine—Stomatitis—Doxorubicin—kidney cancer	0.000186	0.000975	CcSEcCtD
Trimipramine—Thrombocytopenia—Capecitabine—kidney cancer	0.000185	0.000969	CcSEcCtD
Trimipramine—Tachycardia—Capecitabine—kidney cancer	0.000184	0.000965	CcSEcCtD
Trimipramine—Vomiting—Vincristine—kidney cancer	0.000184	0.000965	CcSEcCtD
Trimipramine—CYP2D6—renal system—kidney cancer	0.000183	0.019	CbGeAlD
Trimipramine—Urticaria—Paclitaxel—kidney cancer	0.000183	0.000958	CcSEcCtD
Trimipramine—Rash—Vincristine—kidney cancer	0.000183	0.000957	CcSEcCtD
Trimipramine—Dermatitis—Vincristine—kidney cancer	0.000182	0.000956	CcSEcCtD
Trimipramine—Abdominal pain—Paclitaxel—kidney cancer	0.000182	0.000953	CcSEcCtD
Trimipramine—Body temperature increased—Paclitaxel—kidney cancer	0.000182	0.000953	CcSEcCtD
Trimipramine—Headache—Vincristine—kidney cancer	0.000181	0.000951	CcSEcCtD
Trimipramine—HTR2A—gonad—kidney cancer	0.00018	0.0187	CbGeAlD
Trimipramine—Anorexia—Capecitabine—kidney cancer	0.00018	0.000943	CcSEcCtD
Trimipramine—CYP3A4—kidney—kidney cancer	0.00018	0.0187	CbGeAlD
Trimipramine—Agranulocytosis—Doxorubicin—kidney cancer	0.000178	0.000933	CcSEcCtD
Trimipramine—Epinastine—ABCB1—kidney cancer	0.000178	0.0525	CrCbGaD
Trimipramine—CYP2D6—kidney—kidney cancer	0.000177	0.0184	CbGeAlD
Trimipramine—Hypotension—Capecitabine—kidney cancer	0.000176	0.000924	CcSEcCtD
Trimipramine—Diphenhydramine—PTGS1—kidney cancer	0.000175	0.0516	CrCbGaD
Trimipramine—Vomiting—Gemcitabine—kidney cancer	0.000175	0.000915	CcSEcCtD
Trimipramine—Rash—Gemcitabine—kidney cancer	0.000173	0.000908	CcSEcCtD
Trimipramine—Dermatitis—Gemcitabine—kidney cancer	0.000173	0.000907	CcSEcCtD
Trimipramine—Headache—Gemcitabine—kidney cancer	0.000172	0.000902	CcSEcCtD
Trimipramine—Nausea—Vincristine—kidney cancer	0.000172	0.000902	CcSEcCtD
Trimipramine—Insomnia—Capecitabine—kidney cancer	0.000171	0.000895	CcSEcCtD
Trimipramine—Hypoaesthesia—Doxorubicin—kidney cancer	0.00017	0.000893	CcSEcCtD
Trimipramine—Paraesthesia—Capecitabine—kidney cancer	0.00017	0.000888	CcSEcCtD
Trimipramine—Dyspepsia—Capecitabine—kidney cancer	0.000166	0.000871	CcSEcCtD
Trimipramine—Asthenia—Paclitaxel—kidney cancer	0.000165	0.000865	CcSEcCtD
Trimipramine—Chlorpromazine—BCHE—kidney cancer	0.000165	0.0486	CrCbGaD
Trimipramine—Decreased appetite—Capecitabine—kidney cancer	0.000164	0.00086	CcSEcCtD
Trimipramine—Nausea—Gemcitabine—kidney cancer	0.000163	0.000855	CcSEcCtD
Trimipramine—Fatigue—Capecitabine—kidney cancer	0.000163	0.000853	CcSEcCtD
Trimipramine—Pruritus—Paclitaxel—kidney cancer	0.000163	0.000853	CcSEcCtD
Trimipramine—Constipation—Capecitabine—kidney cancer	0.000161	0.000846	CcSEcCtD
Trimipramine—Tinnitus—Doxorubicin—kidney cancer	0.00016	0.000837	CcSEcCtD
Trimipramine—Flushing—Doxorubicin—kidney cancer	0.000159	0.000833	CcSEcCtD
Trimipramine—Diarrhoea—Paclitaxel—kidney cancer	0.000157	0.000825	CcSEcCtD
Trimipramine—Feeling abnormal—Capecitabine—kidney cancer	0.000156	0.000815	CcSEcCtD
Trimipramine—Arrhythmia—Doxorubicin—kidney cancer	0.000153	0.000802	CcSEcCtD
Trimipramine—Dizziness—Paclitaxel—kidney cancer	0.000152	0.000797	CcSEcCtD
Trimipramine—Alopecia—Doxorubicin—kidney cancer	0.000151	0.000793	CcSEcCtD
Trimipramine—Urticaria—Capecitabine—kidney cancer	0.00015	0.000786	CcSEcCtD
Trimipramine—Abdominal pain—Capecitabine—kidney cancer	0.000149	0.000782	CcSEcCtD
Trimipramine—Body temperature increased—Capecitabine—kidney cancer	0.000149	0.000782	CcSEcCtD
Trimipramine—Vomiting—Paclitaxel—kidney cancer	0.000146	0.000766	CcSEcCtD
Trimipramine—Dysgeusia—Doxorubicin—kidney cancer	0.000146	0.000765	CcSEcCtD
Trimipramine—Rash—Paclitaxel—kidney cancer	0.000145	0.00076	CcSEcCtD
Trimipramine—ABCB1—nephron tubule—kidney cancer	0.000145	0.015	CbGeAlD
Trimipramine—Dermatitis—Paclitaxel—kidney cancer	0.000145	0.000759	CcSEcCtD
Trimipramine—Headache—Paclitaxel—kidney cancer	0.000144	0.000755	CcSEcCtD
Trimipramine—Vision blurred—Doxorubicin—kidney cancer	0.000141	0.000736	CcSEcCtD
Trimipramine—Ill-defined disorder—Doxorubicin—kidney cancer	0.000138	0.000725	CcSEcCtD
Trimipramine—Agitation—Doxorubicin—kidney cancer	0.000137	0.000718	CcSEcCtD
Trimipramine—Nausea—Paclitaxel—kidney cancer	0.000137	0.000716	CcSEcCtD
Trimipramine—Asthenia—Capecitabine—kidney cancer	0.000135	0.00071	CcSEcCtD
Trimipramine—Malaise—Doxorubicin—kidney cancer	0.000134	0.000705	CcSEcCtD
Trimipramine—Pruritus—Capecitabine—kidney cancer	0.000134	0.0007	CcSEcCtD
Trimipramine—Palpitations—Doxorubicin—kidney cancer	0.000132	0.00069	CcSEcCtD
Trimipramine—ABCB1—renal system—kidney cancer	0.000132	0.0137	CbGeAlD
Trimipramine—Convulsion—Doxorubicin—kidney cancer	0.000129	0.000677	CcSEcCtD
Trimipramine—Diarrhoea—Capecitabine—kidney cancer	0.000129	0.000677	CcSEcCtD
Trimipramine—Hypertension—Doxorubicin—kidney cancer	0.000129	0.000675	CcSEcCtD
Trimipramine—ABCB1—kidney—kidney cancer	0.000127	0.0132	CbGeAlD
Trimipramine—Anxiety—Doxorubicin—kidney cancer	0.000127	0.000663	CcSEcCtD
Trimipramine—Discomfort—Doxorubicin—kidney cancer	0.000125	0.000657	CcSEcCtD
Trimipramine—Dizziness—Capecitabine—kidney cancer	0.000125	0.000654	CcSEcCtD
Trimipramine—Dry mouth—Doxorubicin—kidney cancer	0.000124	0.000651	CcSEcCtD
Trimipramine—ABCB1—cortex of kidney—kidney cancer	0.000124	0.0129	CbGeAlD
Trimipramine—Confusional state—Doxorubicin—kidney cancer	0.000123	0.000643	CcSEcCtD
Trimipramine—Oedema—Doxorubicin—kidney cancer	0.000122	0.000638	CcSEcCtD
Trimipramine—Vomiting—Capecitabine—kidney cancer	0.00012	0.000629	CcSEcCtD
Trimipramine—Thrombocytopenia—Doxorubicin—kidney cancer	0.000119	0.000624	CcSEcCtD
Trimipramine—Rash—Capecitabine—kidney cancer	0.000119	0.000624	CcSEcCtD
Trimipramine—Dermatitis—Capecitabine—kidney cancer	0.000119	0.000623	CcSEcCtD
Trimipramine—Tachycardia—Doxorubicin—kidney cancer	0.000119	0.000622	CcSEcCtD
Trimipramine—Headache—Capecitabine—kidney cancer	0.000118	0.00062	CcSEcCtD
Trimipramine—ABCB1—gonad—kidney cancer	0.000118	0.0123	CbGeAlD
Trimipramine—Anorexia—Doxorubicin—kidney cancer	0.000116	0.000608	CcSEcCtD
Trimipramine—Hypotension—Doxorubicin—kidney cancer	0.000114	0.000596	CcSEcCtD
Trimipramine—Nausea—Capecitabine—kidney cancer	0.000112	0.000588	CcSEcCtD
Trimipramine—Carbamazepine—ABCB1—kidney cancer	0.000112	0.033	CrCbGaD
Trimipramine—Insomnia—Doxorubicin—kidney cancer	0.00011	0.000577	CcSEcCtD
Trimipramine—Paraesthesia—Doxorubicin—kidney cancer	0.000109	0.000573	CcSEcCtD
Trimipramine—Somnolence—Doxorubicin—kidney cancer	0.000108	0.000567	CcSEcCtD
Trimipramine—Dyspepsia—Doxorubicin—kidney cancer	0.000107	0.000561	CcSEcCtD
Trimipramine—Decreased appetite—Doxorubicin—kidney cancer	0.000106	0.000554	CcSEcCtD
Trimipramine—Fatigue—Doxorubicin—kidney cancer	0.000105	0.00055	CcSEcCtD
Trimipramine—Constipation—Doxorubicin—kidney cancer	0.000104	0.000545	CcSEcCtD
Trimipramine—Feeling abnormal—Doxorubicin—kidney cancer	0.0001	0.000525	CcSEcCtD
Trimipramine—Urticaria—Doxorubicin—kidney cancer	9.67e-05	0.000507	CcSEcCtD
Trimipramine—Abdominal pain—Doxorubicin—kidney cancer	9.62e-05	0.000504	CcSEcCtD
Trimipramine—Body temperature increased—Doxorubicin—kidney cancer	9.62e-05	0.000504	CcSEcCtD
Trimipramine—Clomipramine—ABCB1—kidney cancer	9.41e-05	0.0278	CrCbGaD
Trimipramine—Asthenia—Doxorubicin—kidney cancer	8.73e-05	0.000458	CcSEcCtD
Trimipramine—Pruritus—Doxorubicin—kidney cancer	8.61e-05	0.000451	CcSEcCtD
Trimipramine—Promethazine—ABCB1—kidney cancer	8.34e-05	0.0246	CrCbGaD
Trimipramine—Diarrhoea—Doxorubicin—kidney cancer	8.33e-05	0.000436	CcSEcCtD
Trimipramine—Doxepin—ABCB1—kidney cancer	8.25e-05	0.0243	CrCbGaD
Trimipramine—Methadone—ABCB1—kidney cancer	8.21e-05	0.0242	CrCbGaD
Trimipramine—Dizziness—Doxorubicin—kidney cancer	8.05e-05	0.000422	CcSEcCtD
Trimipramine—Vomiting—Doxorubicin—kidney cancer	7.74e-05	0.000405	CcSEcCtD
Trimipramine—Rash—Doxorubicin—kidney cancer	7.67e-05	0.000402	CcSEcCtD
Trimipramine—Dermatitis—Doxorubicin—kidney cancer	7.67e-05	0.000402	CcSEcCtD
Trimipramine—Headache—Doxorubicin—kidney cancer	7.63e-05	0.000399	CcSEcCtD
Trimipramine—Desipramine—ABCB1—kidney cancer	7.57e-05	0.0223	CrCbGaD
Trimipramine—Nausea—Doxorubicin—kidney cancer	7.23e-05	0.000379	CcSEcCtD
Trimipramine—Chlorpromazine—ABCB1—kidney cancer	6.45e-05	0.019	CrCbGaD
Trimipramine—Imipramine—ABCB1—kidney cancer	6.42e-05	0.0189	CrCbGaD
Trimipramine—Amitriptyline—ABCB1—kidney cancer	6.38e-05	0.0188	CrCbGaD
Trimipramine—CYP2C19—Metabolism—CYP1A1—kidney cancer	5.39e-06	9.91e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ABCB1—kidney cancer	5.38e-06	9.9e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ACHE—kidney cancer	5.36e-06	9.86e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTT1—kidney cancer	5.36e-06	9.86e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—APC—kidney cancer	5.36e-06	9.86e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—KIT—kidney cancer	5.36e-06	9.86e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ABCB1—kidney cancer	5.34e-06	9.81e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—MAPK3—kidney cancer	5.33e-06	9.8e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—POMC—kidney cancer	5.3e-06	9.74e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CYP1A1—kidney cancer	5.26e-06	9.67e-05	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—PIK3CA—kidney cancer	5.25e-06	9.66e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—MAPK3—kidney cancer	5.24e-06	9.64e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—MAPK3—kidney cancer	5.23e-06	9.62e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—BRAF—kidney cancer	5.23e-06	9.62e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GSTM1—kidney cancer	5.23e-06	9.61e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—POMC—kidney cancer	5.21e-06	9.58e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—POMC—kidney cancer	5.2e-06	9.56e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—KRAS—kidney cancer	5.19e-06	9.55e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—PIK3CA—kidney cancer	5.19e-06	9.54e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GSTM1—kidney cancer	5.18e-06	9.53e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—RAF1—kidney cancer	5.15e-06	9.47e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—BRAF—kidney cancer	5.15e-06	9.46e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—BRAF—kidney cancer	5.13e-06	9.44e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—MAPK3—kidney cancer	5.13e-06	9.44e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—RELA—kidney cancer	5.13e-06	9.43e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—POMC—kidney cancer	5.1e-06	9.38e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—ERBB2—kidney cancer	5.1e-06	9.37e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—VEGFA—kidney cancer	5.08e-06	9.34e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—SCARB1—kidney cancer	5.08e-06	9.34e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—MAPK1—kidney cancer	5.07e-06	9.32e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—BRAF—kidney cancer	5.04e-06	9.26e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MTOR—kidney cancer	5.03e-06	9.25e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTGS1—kidney cancer	5.03e-06	9.24e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—PIK3CA—kidney cancer	5.01e-06	9.21e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—MAPK1—kidney cancer	4.99e-06	9.17e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—PIK3CA—kidney cancer	4.98e-06	9.17e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—APC—kidney cancer	4.98e-06	9.16e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—KIT—kidney cancer	4.98e-06	9.16e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—MAPK1—kidney cancer	4.98e-06	9.15e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—RAF1—kidney cancer	4.97e-06	9.14e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.95e-06	9.11e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—RELA—kidney cancer	4.95e-06	9.1e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—RAF1—kidney cancer	4.95e-06	9.1e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PSMD7—kidney cancer	4.93e-06	9.06e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—RELA—kidney cancer	4.93e-06	9.06e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—ERBB2—kidney cancer	4.92e-06	9.05e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.91e-06	9.03e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—ERBB2—kidney cancer	4.89e-06	9e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—MAPK1—kidney cancer	4.88e-06	8.98e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MTOR—kidney cancer	4.85e-06	8.93e-05	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—PIK3CA—kidney cancer	4.84e-06	8.91e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MTOR—kidney cancer	4.83e-06	8.88e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MAPK3—kidney cancer	4.81e-06	8.84e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—KRAS—kidney cancer	4.79e-06	8.8e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—PIK3CA—kidney cancer	4.77e-06	8.77e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—MAPK3—kidney cancer	4.77e-06	8.77e-05	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—PIK3CA—kidney cancer	4.77e-06	8.76e-05	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—PIK3CA—kidney cancer	4.76e-06	8.75e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—POMC—kidney cancer	4.74e-06	8.72e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—RAF1—kidney cancer	4.74e-06	8.71e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CDKN1B—kidney cancer	4.72e-06	8.68e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—RELA—kidney cancer	4.71e-06	8.67e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—KRAS—kidney cancer	4.71e-06	8.66e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—KRAS—kidney cancer	4.7e-06	8.64e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ERBB2—kidney cancer	4.69e-06	8.62e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—BRAF—kidney cancer	4.68e-06	8.61e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MYC—kidney cancer	4.67e-06	8.59e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—BCHE—kidney cancer	4.67e-06	8.59e-05	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	4.67e-06	8.58e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MTOR—kidney cancer	4.62e-06	8.5e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL2—kidney cancer	4.62e-06	8.49e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.62e-06	8.49e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	4.61e-06	8.48e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MAPK1—kidney cancer	4.57e-06	8.41e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CDKN1B—kidney cancer	4.56e-06	8.38e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—MAPK1—kidney cancer	4.54e-06	8.34e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CDKN1B—kidney cancer	4.53e-06	8.33e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PTGS2—kidney cancer	4.52e-06	8.31e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CCND1—kidney cancer	4.5e-06	8.28e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—JUN—kidney cancer	4.49e-06	8.26e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CTNNB1—kidney cancer	4.46e-06	8.2e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL2—kidney cancer	4.46e-06	8.2e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.46e-06	8.2e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL2—kidney cancer	4.44e-06	8.16e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.43e-06	8.14e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	4.4e-06	8.09e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—RAF1—kidney cancer	4.37e-06	8.03e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—RELA—kidney cancer	4.35e-06	7.99e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCND1—kidney cancer	4.35e-06	7.99e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PTEN—kidney cancer	4.35e-06	7.99e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CDKN1B—kidney cancer	4.34e-06	7.98e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—JUN—kidney cancer	4.34e-06	7.98e-05	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	4.34e-06	7.97e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	4.33e-06	7.96e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCND1—kidney cancer	4.32e-06	7.95e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ERBB2—kidney cancer	4.32e-06	7.94e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	4.32e-06	7.94e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—KRAS—kidney cancer	4.32e-06	7.94e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—JUN—kidney cancer	4.31e-06	7.93e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	4.3e-06	7.91e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—RAF1—kidney cancer	4.3e-06	7.9e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—RAF1—kidney cancer	4.29e-06	7.88e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	4.29e-06	7.88e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	4.28e-06	7.87e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—RELA—kidney cancer	4.28e-06	7.86e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—RELA—kidney cancer	4.27e-06	7.85e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MTOR—kidney cancer	4.26e-06	7.84e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ERBB2—kidney cancer	4.25e-06	7.82e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL2—kidney cancer	4.25e-06	7.81e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ERBB2—kidney cancer	4.24e-06	7.8e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	4.24e-06	7.79e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—RAF1—kidney cancer	4.21e-06	7.73e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PTEN—kidney cancer	4.2e-06	7.71e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MTOR—kidney cancer	4.19e-06	7.71e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—RELA—kidney cancer	4.19e-06	7.7e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MTOR—kidney cancer	4.19e-06	7.7e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PTEN—kidney cancer	4.17e-06	7.67e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	4.16e-06	7.65e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCND1—kidney cancer	4.14e-06	7.61e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—JUN—kidney cancer	4.13e-06	7.6e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MTOR—kidney cancer	4.11e-06	7.55e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	4.1e-06	7.54e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.04e-06	7.42e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—POMC—kidney cancer	4.02e-06	7.39e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CDKN1B—kidney cancer	4e-06	7.36e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PTEN—kidney cancer	4e-06	7.35e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	3.97e-06	7.3e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PTEN—kidney cancer	3.94e-06	7.25e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	3.94e-06	7.24e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	3.94e-06	7.24e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	3.93e-06	7.22e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VEGFA—kidney cancer	3.93e-06	7.22e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—POMC—kidney cancer	3.92e-06	7.21e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL2—kidney cancer	3.91e-06	7.2e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RAF1—kidney cancer	3.91e-06	7.19e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RELA—kidney cancer	3.89e-06	7.16e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	3.87e-06	7.11e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	3.85e-06	7.09e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL2—kidney cancer	3.85e-06	7.08e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL2—kidney cancer	3.84e-06	7.07e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—kidney cancer	3.84e-06	7.06e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCND1—kidney cancer	3.82e-06	7.02e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MTOR—kidney cancer	3.82e-06	7.02e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—JUN—kidney cancer	3.81e-06	7e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VEGFA—kidney cancer	3.79e-06	6.97e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	3.78e-06	6.95e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL2—kidney cancer	3.77e-06	6.94e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VEGFA—kidney cancer	3.77e-06	6.93e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCND1—kidney cancer	3.75e-06	6.9e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—JUN—kidney cancer	3.75e-06	6.89e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCND1—kidney cancer	3.75e-06	6.89e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—JUN—kidney cancer	3.74e-06	6.88e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	3.72e-06	6.84e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTP1—kidney cancer	3.72e-06	6.84e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK3—kidney cancer	3.71e-06	6.83e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	3.71e-06	6.82e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—POMC—kidney cancer	3.69e-06	6.79e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PTEN—kidney cancer	3.68e-06	6.77e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCND1—kidney cancer	3.68e-06	6.76e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—JUN—kidney cancer	3.67e-06	6.75e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—POMC—kidney cancer	3.66e-06	6.73e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	3.64e-06	6.7e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PTEN—kidney cancer	3.62e-06	6.66e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PTEN—kidney cancer	3.62e-06	6.65e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MYC—kidney cancer	3.61e-06	6.64e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	3.61e-06	6.64e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK3—kidney cancer	3.58e-06	6.59e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	3.58e-06	6.58e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK3—kidney cancer	3.57e-06	6.56e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PTEN—kidney cancer	3.55e-06	6.53e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK1—kidney cancer	3.53e-06	6.5e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ABCB1—kidney cancer	3.52e-06	6.47e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL2—kidney cancer	3.5e-06	6.44e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MYC—kidney cancer	3.49e-06	6.41e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MYC—kidney cancer	3.47e-06	6.38e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTM1—kidney cancer	3.42e-06	6.28e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCND1—kidney cancer	3.42e-06	6.28e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	3.41e-06	6.28e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK1—kidney cancer	3.41e-06	6.27e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—JUN—kidney cancer	3.41e-06	6.27e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK1—kidney cancer	3.39e-06	6.24e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	3.38e-06	6.22e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—KRAS—kidney cancer	3.34e-06	6.14e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VEGFA—kidney cancer	3.33e-06	6.12e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MYC—kidney cancer	3.32e-06	6.11e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PTEN—kidney cancer	3.3e-06	6.06e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VEGFA—kidney cancer	3.27e-06	6.02e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VEGFA—kidney cancer	3.27e-06	6.01e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	3.25e-06	5.97e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.24e-06	5.96e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—KRAS—kidney cancer	3.22e-06	5.92e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	3.21e-06	5.89e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—KRAS—kidney cancer	3.2e-06	5.89e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTGS2—kidney cancer	3.2e-06	5.89e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK3—kidney cancer	3.15e-06	5.79e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTGS2—kidney cancer	3.13e-06	5.75e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK3—kidney cancer	3.1e-06	5.69e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK3—kidney cancer	3.09e-06	5.68e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—KRAS—kidney cancer	3.07e-06	5.64e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PIK3CA—kidney cancer	3.07e-06	5.64e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MYC—kidney cancer	3.06e-06	5.63e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	3.03e-06	5.58e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MYC—kidney cancer	3.01e-06	5.54e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MYC—kidney cancer	3.01e-06	5.53e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK1—kidney cancer	2.99e-06	5.51e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	2.98e-06	5.48e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—kidney cancer	2.97e-06	5.45e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	2.96e-06	5.44e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MYC—kidney cancer	2.95e-06	5.42e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK1—kidney cancer	2.95e-06	5.42e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTGS2—kidney cancer	2.95e-06	5.42e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	2.94e-06	5.41e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK1—kidney cancer	2.94e-06	5.41e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTGS2—kidney cancer	2.92e-06	5.37e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	2.89e-06	5.31e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—kidney cancer	2.86e-06	5.26e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—kidney cancer	2.85e-06	5.24e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—KRAS—kidney cancer	2.83e-06	5.2e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	2.82e-06	5.18e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	2.82e-06	5.18e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTEN—kidney cancer	2.79e-06	5.14e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—KRAS—kidney cancer	2.78e-06	5.12e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PIK3CA—kidney cancer	2.78e-06	5.12e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—KRAS—kidney cancer	2.78e-06	5.11e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MYC—kidney cancer	2.74e-06	5.04e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTEN—kidney cancer	2.73e-06	5.01e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—kidney cancer	2.73e-06	5.01e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—KRAS—kidney cancer	2.72e-06	5.01e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	2.68e-06	4.93e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	2.6e-06	4.78e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTEN—kidney cancer	2.57e-06	4.72e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	2.56e-06	4.7e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	2.55e-06	4.69e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTEN—kidney cancer	2.55e-06	4.68e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—KRAS—kidney cancer	2.53e-06	4.66e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—kidney cancer	2.51e-06	4.62e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	2.5e-06	4.6e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—kidney cancer	2.47e-06	4.55e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—kidney cancer	2.47e-06	4.54e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—kidney cancer	2.42e-06	4.45e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—POMC—kidney cancer	2.42e-06	4.44e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	2.33e-06	4.28e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—kidney cancer	2.25e-06	4.14e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.97e-06	3.62e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.93e-06	3.54e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.92e-06	3.54e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.81e-06	3.33e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.8e-06	3.3e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTEN—kidney cancer	1.68e-06	3.09e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.19e-06	2.18e-05	CbGpPWpGaD
